Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,636 | 3,363 | 9,256 | 5,578 | 9,432 |
| Receivables | 1,613 | 209 | 85 | 161 | 484 |
| Inventories | 410 | 232 | N/A | N/A | N/A |
| Other current assets | 279 | 362 | 32 | 61 | 139 |
| TOTAL | $11,759 | $4,793 | $9,968 | $6,535 | $10,698 |
| Non-Current Assets | |||||
| PPE Net | 3,567 | 3,494 | 3,347 | 3,528 | 3,799 |
| Intangibles | 14,607 | 56,529 | 56,551 | 56,573 | 56,595 |
| Other Non-Current Assets | 5,148 | 5,400 | 4,854 | 4,337 | 3,800 |
| TOTAL | $23,322 | $65,423 | $64,752 | $64,438 | $64,194 |
| Total Assets | $35,081 | $70,216 | $74,720 | $70,973 | $74,892 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,279 | 872 | 1,051 | 908 | 953 |
| Accrued Expenses | 3,473 | 6,321 | 5,118 | 6,598 | 3,217 |
| Other current liabilities | 228 | 614 | N/A | N/A | 2,314 |
| TOTAL | $7,275 | $9,090 | $7,198 | $8,327 | $7,194 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 51,415 | 44,819 | 51,058 | 47,230 |
| TOTAL | $40,080 | $51,415 | $44,819 | $51,058 | $47,230 |
| Total Liabilities | $47,355 | $60,505 | $52,017 | $59,385 | $54,424 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,599 | 16,835 | 13,368 | 13,365 | 8,273 |
| Common Shares | 338,244 | 326,682 | 326,201 | 310,553 | 310,295 |
| Retained earnings | -350,539 | -317,028 | -303,535 | -299,005 | -289,876 |
| Other shareholders' equity | 21 | 57 | 37 | 40 | 49 |
| TOTAL | $-12,274 | $9,711 | $22,703 | $11,588 | $20,468 |
| Total Liabilities And Equity | $35,081 | $70,216 | $74,720 | $70,973 | $74,892 |